Literature DB >> 30684231

Importance of and Satisfaction with Information about Their Disease in Cancer Patients.

Hannah Eisfeld1, Fabienne Bauer1, Clara Dubois1, Thorsten Schmidt2, Karin Kastrati3, Andreas Hochhaus1, Jutta Hübner4.   

Abstract

To learn more about information needs and satisfaction with provided information among cancer patients and whether dissatisfaction with information has any association with how therapy decisions are made. An online survey was conducted during March 2015 and January 2016 by the German non-profit patient organization "Das Lebenshaus e.V." among their members with rare solid tumors. A total of 338 records was analyzed. The majority found information on their disease important and was satisfied with the provided information. The participants were less satisfied with the information concerning management of side effects than with other aspects of information (p < .001). Support groups, lectures, and the oncologist were rated as the most helpful sources of information followed by a second opinion and media. Participants who were dissatisfied with the information more often made the decision on the treatment alone by themselves (p < .001). Our results show a high satisfaction with disease-related information among our study participants. Improvements could be made by offering more information on the management of side effects and by giving more information about support groups, reliable websites, and other helpful media.

Entities:  

Keywords:  Patient information needs; Patient lectures; Patient support groups; Satisfaction with information; Shared decision-making

Year:  2020        PMID: 30684231     DOI: 10.1007/s13187-019-1480-7

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  1 in total

1.  Cancer Patient Motives and Expectations on Non-medical Practitioners.

Authors:  Christian Keinki; Emadaldin Ahmadi; Karin Kastrati; Bijan Zomorodbakhsch; Jutta Hübner
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.